26.8 C
New York
Thursday, July 3, 2025

Tag: park

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted eight newly-hired employees restricted stock units (RSUs) covering an aggregate of 57,000 shares of BioCryst common stock. The RSUs were granted as of July 1, 2025, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

JW Marriott Phu Quoc Unlocks a Season of Discovery with New Summer Offer

PHU QUOC, Vietnam, July 3, 2025 /PRNewswire/ -- There's a certain kind of magic in Phu Quoc – Vietnam's most celebrated island: golden mornings,...

HUTCHMED to Announce 2025 Half-Year Financial Results

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT).

Wynn Al Marjan Island Debuts Enclave: A Destination Within a Destination

RAS AL KHAIMAH, UAE, July 2, 2025 /PRNewswire/ -- Wynn Al Marjan Island, slated to open in early 2027 in Ras Al Khaimah, United...

TopLine Credit Union Members And Employees Donate Clothing And Shoes

TopLine’s Clothing and Shoe Drive Benefits Local Organizations

Ramen Arashi Langford Announces Official Grand Opening: July 9th

LANGFORD, BC, July 2, 2025 /CNW/ - After months of anticipation, Ramen Arashi Langford will officially open its doors on Tuesday, July 9th, bringing authentic...

FOOD, FLAVOR AND FESTIVITIES: WORLD FOOD & MUSIC FESTIVAL 2025 VENDORS ANNOUNCED

GREATER DES MOINES, Iowa, July 2, 2025 /PRNewswire/ -- The World Food & Music Festival presented by Veridian Credit Union has announced vendors, merchants and...

Cyclists of All Ages and Abilities to Unite for Blood Cancer Patients Along Picturesque Lake Michigan Shoreline

The Leukemia & Lymphoma Society's Scenic Shore Bike Tour Offers a Unique Ride Experience to Help Advance Lifesaving Research, Support, and Advocacy WASHINGTON, July 2,...

FG Communities Completes Acquisition in Myrtle Beach, SC

FG Communities Completes Acquisition in Myrtle Beach, SC

Journalists from Asia and North Africa Explore Gansu’s Cultural Heritage and Rural Innovation

TIANSHUI, China, July 2, 2025 /PRNewswire/ -- Reporters representing media outlets in Cambodia, Japan, South Korea, Myanmar, Morocco, Thailand, and Vietnam recently completed a week-long...

EQV Ventures Acquisition Corp. II Announces the Pricing of Upsized $420 Million Initial Public Offering

PARK CITY, UTAH, July 01, 2025 (GLOBE NEWSWIRE) -- EQV Ventures Acquisition Corp. II (the “Company”), a special purpose acquisition company sponsored by an affiliate of the EQV Group, and formed for the purpose of entering into a business combination with one or more businesses, announced today the pricing of its initial public offering of 42,000,000 units, upsized from 35,000,000 units, at a price of $10.00 per unit. The units are expected to be listed on the New York Stock Exchange (“NYSE”) and begin trading tomorrow, July 2, 2025, under the ticker symbol “EVACU.”

Labubu Mania Finds New Home on Palmstreet Live Auctions, Launching 31 Days of Daily Giveaways

Live Shopping App Palmstreet Launches Collectibles Market with Coveted Labubu Resellers and Daily Prize Campaign MENLO PARK, Calif., July 1, 2025 /PRNewswire/ -- Palmstreet, the...

Dixxon Flannel Co. Announces Partnership with Black Sabbath’s “Back to the Beginning” Festival

Brand Rooted in Rock Music Celebrates Heavy Metal Legends and Supports Charitable Causes TEMPE, Ariz., July 1, 2025 /PRNewswire/ -- Dixxon Flannel Co. is thrilled...

Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering

FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the pricing of an underwritten public offering for gross proceeds of approximately $6 million prior to deducting underwriting commissions and offering expenses.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPark